Newspatrolling.com News cum Content Syndication Portal Online

Breaking News

From Speed to Experience: The Next Era of Home Internet in India
ONYX Hospitality Group Partners with Yee Fung Group to Launch “Y Hotel Nanshan Shenzhen”, Expanding its Portfolio in China
VF 8 Is Connecting a New Global VinFast Community
From Messaging to Commerce, ~90% of Bharat Consumers Use WhatsApp as Their Primary Digital Platform: Finds Rukam Capital Study – Beyond Metros: The Real Story of Bharat’s Next 500 Million
Analog Devices 2026 Predictions: AI Gets Physical

Alembic Pharmaceuticals Receives USFDA EIR for Karakhadi API-III Facility

Naman Bansal June 19, 2025 PR

19 May, 2025, Bengaluru: Alembic Pharmaceuticals Limited has received the Establishment Inspection Report (EIR) from the US Food and Drug Administration (USFDA) for its API-III manufacturing facility located at Karakhadi, Gujarat.

The inspection was conducted from 17^th March, 2025 to 21^st March, 2025.

Related Articles

Check Also

India’s expectations on Impact Consciousness by businesses and government higher than global averages: SEC Newgate 2025 Impact Monitor Across 20 Countries

With strong awareness, understanding and interest in responsible business and ESG, India holds organizations to …